106 related articles for article (PubMed ID: 17476595)
21. Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?
Böhner H; Zimmer T; Hopfenmüller W; Berger G; Buhr HJ
Hepatogastroenterology; 2000; 47(35):1489-94. PubMed ID: 11100384
[TBL] [Abstract][Full Text] [Related]
22. Better outcomes by monitoring tumour dynamics using sensitive tumour markers in patients with recurrent gastric cancer.
Komatsu S; Ichikawa D; Nishimura Y; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
Anticancer Res; 2013 Apr; 33(4):1621-7. PubMed ID: 23564806
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.
Cao L; Selby LV; Hu X; Zhang Y; Janjigian YY; Tang L; Coit DG; Brennan MF; Strong VE
J Surg Oncol; 2016 Jun; 113(7):745-9. PubMed ID: 27040753
[TBL] [Abstract][Full Text] [Related]
24. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
25. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
[TBL] [Abstract][Full Text] [Related]
26. Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Baiocchi GL; Marrelli D; Verlato G; Morgagni P; Giacopuzzi S; Coniglio A; Marchet A; Rosa F; Capponi MG; Di Leo A; Saragoni L; Ansaloni L; Pacelli F; Nitti D; D'Ugo D; Roviello F; Tiberio GA; Giulini SM; De Manzoni G
Ann Surg Oncol; 2014 Jun; 21(6):2005-11. PubMed ID: 24526547
[TBL] [Abstract][Full Text] [Related]
27. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
28. Short-term and long-term risk factors in gastric cancer.
Verlato G; Marrelli D; Accordini S; Bencivenga M; Di Leo A; Marchet A; Petrioli R; Zoppini G; Muggeo M; Roviello F; de Manzoni G
World J Gastroenterol; 2015 Jun; 21(21):6434-43. PubMed ID: 26074682
[TBL] [Abstract][Full Text] [Related]
29. Factors correlated with early and late recurrence after curative gastrectomy for gastric cancer.
Ogata K; Mochiki E; Yanai M; Toyomasu Y; Ando H; Ohno T; Aihara R; Asao T; Kuwano H
Hepatogastroenterology; 2009; 56(96):1760-4. PubMed ID: 20214233
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.
Li Y; Yang Y; Lu M; Shen L
Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic versus open gastrectomy for gastric cancer: long-term oncologic results.
Lee JH; Lee CM; Son SY; Ahn SH; Park DJ; Kim HH
Surgery; 2014 Jan; 155(1):154-64. PubMed ID: 24238126
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node mapping for 385 gastric cancer patients.
Niihara M; Takeuchi H; Nakahara T; Saikawa Y; Takahashi T; Wada N; Mukai M; Kitagawa Y
J Surg Res; 2016 Jan; 200(1):73-81. PubMed ID: 26233688
[TBL] [Abstract][Full Text] [Related]
33. The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.
Wada N; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Surg Today; 2017 Feb; 47(2):227-232. PubMed ID: 27566604
[TBL] [Abstract][Full Text] [Related]
34. Patterns, timing and risk factors of recurrence of gastric cancer after laparoscopic gastrectomy: reliable results following long-term follow-up.
Nakagawa M; Kojima K; Inokuchi M; Kato K; Sugita H; Kawano T; Sugihara K
Eur J Surg Oncol; 2014 Oct; 40(10):1376-82. PubMed ID: 24915857
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M
Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555
[TBL] [Abstract][Full Text] [Related]
36. Expression of eukaryotic initiation factor 3f is associated with prognosis in gastric carcinomas.
Cheng Y; Jia C; Li G; Li H
Oncol Res Treat; 2014; 37(4):198-202. PubMed ID: 24732644
[TBL] [Abstract][Full Text] [Related]
37. Urinary pepsinogen I as a tumor marker of stomach cancer after total gastrectomy.
Yamaguchi T; Takahashi T; Yokota T; Kitamura K; Noguchi A; Kamiguchi M; Doi M; Ahn T; Sawai K; Yamane T
Cancer; 1991 Aug; 68(4):906-9. PubMed ID: 1649690
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of non-curative gastrectomy for incurable gastric carcinoma.
Jeong O; Park YK; Choi WY; Ryu SY
Ann Surg Oncol; 2014 Aug; 21(8):2587-93. PubMed ID: 24633671
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
40. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
